These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Human Colon Organoids and Other Laboratory Strategies to Enhance Patient Treatment Selection. Johnson KA; DeStefanis RA; Emmerich PB; Grogan PT; Kratz JD; Makkar SK; Clipson L; Deming DA Curr Treat Options Oncol; 2020 Apr; 21(5):35. PubMed ID: 32328818 [TBL] [Abstract][Full Text] [Related]
5. Organoid Models of Colorectal Pathology: Do They Hold the Key to Personalized Medicine? A Systematic Review. DeHaan RK; Sarvestani SK; Huang EH Dis Colon Rectum; 2020 Nov; 63(11):1559-1569. PubMed ID: 32868555 [TBL] [Abstract][Full Text] [Related]
6. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer. Xie BY; Wu AW Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340 [TBL] [Abstract][Full Text] [Related]
7. Deciphering the Tumor Microenvironment of Colorectal Cancer and Guiding Clinical Treatment With Patient-Derived Organoid Technology: Progress and Challenges. Li J; Liu J; Xia W; Yang H; Sha W; Chen H Technol Cancer Res Treat; 2024; 23():15330338231221856. PubMed ID: 38225190 [TBL] [Abstract][Full Text] [Related]
8. Modeling colorectal cancers using multidimensional organoids. Sayed IM; El-Hafeez AAA; Maity PP; Das S; Ghosh P Adv Cancer Res; 2021; 151():345-383. PubMed ID: 34148617 [TBL] [Abstract][Full Text] [Related]
9. Emerging Prospects for the Study of Colorectal Cancer Stem Cells using Patient-derived Organoids. Ding L; Yang Y; Lu Q; Cao Z; Weygant N Curr Cancer Drug Targets; 2022; 22(3):195-208. PubMed ID: 35078398 [TBL] [Abstract][Full Text] [Related]
10. Patient-derived organoids as a preclinical platform for precision medicine in colorectal cancer. Cho YW; Min DW; Kim HP; An Y; Kim S; Youk J; Chun J; Im JP; Song SH; Ju YS; Han SW; Park KJ; Kim TY Mol Oncol; 2022 Jun; 16(12):2396-2412. PubMed ID: 34850547 [TBL] [Abstract][Full Text] [Related]
11. Patient-Derived Organoids of Cholangiocarcinoma. Maier CF; Zhu L; Nanduri LK; Kühn D; Kochall S; Thepkaysone ML; William D; Grützmann K; Klink B; Betge J; Weitz J; Rahbari NN; Reißfelder C; Schölch S Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445380 [TBL] [Abstract][Full Text] [Related]
12. Current Applications of Colorectal Cancer Organoids: A Review. Ban QY; Li HS; Jiang XX; Liu M; Ge XY; Lu MJ; Guo SY; Chen Y; Lin Q; Xu H; He WQ; Ding N; Zha JM J Gastrointestin Liver Dis; 2024 Jun; 33(2):269-277. PubMed ID: 38944855 [TBL] [Abstract][Full Text] [Related]
13. Systematic evaluation of colorectal cancer organoid system by single-cell RNA-Seq analysis. Wang R; Mao Y; Wang W; Zhou X; Wang W; Gao S; Li J; Wen L; Fu W; Tang F Genome Biol; 2022 Apr; 23(1):106. PubMed ID: 35484598 [TBL] [Abstract][Full Text] [Related]
14. Personalized Proteome Profiles of Healthy and Tumor Human Colon Organoids Reveal Both Individual Diversity and Basic Features of Colorectal Cancer. Cristobal A; van den Toorn HWP; van de Wetering M; Clevers H; Heck AJR; Mohammed S Cell Rep; 2017 Jan; 18(1):263-274. PubMed ID: 28052255 [TBL] [Abstract][Full Text] [Related]
15. Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases. Weeber F; van de Wetering M; Hoogstraat M; Dijkstra KK; Krijgsman O; Kuilman T; Gadellaa-van Hooijdonk CG; van der Velden DL; Peeper DS; Cuppen EP; Vries RG; Clevers H; Voest EE Proc Natl Acad Sci U S A; 2015 Oct; 112(43):13308-11. PubMed ID: 26460009 [TBL] [Abstract][Full Text] [Related]
16. Organoid screening reveals epigenetic vulnerabilities in human colorectal cancer. Toshimitsu K; Takano A; Fujii M; Togasaki K; Matano M; Takahashi S; Kanai T; Sato T Nat Chem Biol; 2022 Jun; 18(6):605-614. PubMed ID: 35273398 [TBL] [Abstract][Full Text] [Related]
17. Development of a system combining comprehensive genotyping and organoid cultures for identifying and testing genotype-oriented personalised medicine for pancreatobiliary cancers. Shiihara M; Ishikawa T; Saiki Y; Omori Y; Hirose K; Fukushige S; Ikari N; Higuchi R; Yamamoto M; Morikawa T; Nakagawa K; Hayashi H; Mizuma M; Ohtsuka H; Motoi F; Unno M; Okamura Y; Kinoshita K; Furukawa T Eur J Cancer; 2021 May; 148():239-250. PubMed ID: 33752134 [TBL] [Abstract][Full Text] [Related]
18. Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma. Ramzy GM; Norkin M; Koessler T; Voirol L; Tihy M; Hany D; McKee T; Ris F; Buchs N; Docquier M; Toso C; Rubbia-Brandt L; Bakalli G; Guerrier S; Huelsken J; Nowak-Sliwinska P J Exp Clin Cancer Res; 2023 Apr; 42(1):79. PubMed ID: 37013646 [TBL] [Abstract][Full Text] [Related]
19. Tumor organoids: applications in cancer modeling and potentials in precision medicine. Xu H; Jiao D; Liu A; Wu K J Hematol Oncol; 2022 May; 15(1):58. PubMed ID: 35551634 [TBL] [Abstract][Full Text] [Related]
20. Disease Modeling on Tumor Organoids Implicates AURKA as a Therapeutic Target in Liver Metastatic Colorectal Cancer. Boos SL; Loevenich LP; Vosberg S; Engleitner T; Öllinger R; Kumbrink J; Rokavec M; Michl M; Greif PA; Jung A; Hermeking H; Neumann J; Kirchner T; Rad R; Jung P Cell Mol Gastroenterol Hepatol; 2022; 13(2):517-540. PubMed ID: 34700030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]